Compound information
- Natural Products
- ZC253488
- Molecular Formula
- C25H38N6O6
- Molecular Weight
- 518.285282936 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2S)-1-[(2R)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C25H38N6O6/c1-25(2,3)37-24(36)30-18(15-16-9-5-4-6-10-16)21(33)31-14-8-12-19(31)20(32)29-17(22(34)35)11-7-13-28-23(26)27/h4-6,9-10,17-19H,7-8,11-15H2,1-3H3,(H,29,32)(H,30,36)(H,34,35)(H4,26,27,28)/t17-,18+,19-/m0/s1
- InChI Key
- CBJCGSXEQDJZCG-OTWHNJEPSA-N
- SMILES
- CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
- Source
- ZINC000015721233
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 2 |
Heteroatom Count | 12 | Rotatable Bond Count | 11 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 186.94 Å2 | LogP | 0.616 |
LogS | -2.888 | LogD | 0.372 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.986 |
HIA | 0.0 | F20 % | 0.105 |
F30 % | 0.0 | Caco-2 | -6.886 |
MDCK | -5.894 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.643 | PPB | 58.245 |
VD | 0.439 | Fu | 0.381 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.404 |
CYP2A6 substrate | 0.275 | CYP2B6 substrate | 0.406 |
CYP2C19 inhibitor | 0.052 | CYP2C19 substrate | 0.889 |
CYP2C8 substrate | 0.423 | CYP2C9 inhibitor | 0.06 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.478 | CYP2E1 substrate | 0.327 |
CYP3A4 inhibitor | 0.003 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.874 | CL | 4.866 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.347 | Hepatotoxicity | 0.189 |
Mutagenicity | 0.016 | Rat Oral Acute Toxicity | 0.047 |
FDAMDD | 0.62 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.003 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.129 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.82 | IGC50 | 1.651 |
LC50FM | 0.048 | LC50DM | -0.689 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.393 | NR-AR-LBD | 0.339 |
NR-AhR | 0.008 | NR-Aromatase | 0.026 |
NR-ER | 0.452 | NR-ER-LBD | 0.422 |
NR-PPAR-gamma | 0.517 | SR-ARE | 0.315 |
SR-ATAD5 | 0.352 | SR-HSE | 0.092 |
SR-MMP | 0.009 | SR-p53 | 0.054 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.